Clinical Trials Directory

Trials / Completed

CompletedNCT03035084

Is Vitamin D2 Treatment-associated Decrease in 25(OH)D3 Level a Reciprocal Phenomena?

Is Vitamin D2 Treatment-associated Decrease in 25(OH)D3 Level a Reciprocal Phenomena? A Randomized Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (actual)
Sponsor
King Faisal Specialist Hospital & Research Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Several studies have demonstrated that D2 treatment is associated with a decrease in 25(OH)D3 level and therefore have proposed that D3 would be preferable in term of raising total 25(OH)D level. The investigators postulate that the D2 treatment-associated decrease in 25(OH)D3 level may be related to an increase in total 25(OH)D level rather than being specific to D2 treatment, and thus there would be a D3 treatment-associated decrease in 25(OH)D2 level. The investigators plan to conduct a double-blind placebo-controlled trial to examine the effect of D3 treatment on 25(OH)D2 level and the effect of D2 treatment on 25(OH)D3 leve

Conditions

Interventions

TypeNameDescription
DRUGVitamin D3Single oral dose of 50,000 IU of vitamin D3
DRUGVitamin D2Single oral dose of 50,000 IU of vitamin D2
DRUGPlacebo oral capsulePlacebo oral capsule

Timeline

Start date
2017-02-15
Primary completion
2017-11-20
Completion
2017-11-20
First posted
2017-01-27
Last updated
2018-08-13

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT03035084. Inclusion in this directory is not an endorsement.